OTC and FDA Registration
Friday, August 16, 2019
LAMISIL AT CONTINUOUS (Terbinafine Hydrochloride) Liquid [GlaxoSmithKline Consumer Healthcare Holdings (US) LLC]
Updated Date: Mon, 12 Aug 2019 00:00:00 EDT
from
https://fda.report/DailyMed/8a8f2d12-a621-4334-b790-7879704aeff8
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment